220 related articles for article (PubMed ID: 28239073)
1. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
[TBL] [Abstract][Full Text] [Related]
2. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
[TBL] [Abstract][Full Text] [Related]
3. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
[TBL] [Abstract][Full Text] [Related]
4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
5. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
6. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
[TBL] [Abstract][Full Text] [Related]
7. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
[TBL] [Abstract][Full Text] [Related]
8. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion.
Zhao J; Di T; Wang Y; Wang Y; Liu X; Liang D; Li P
Eur J Pharmacol; 2016 Feb; 772():131-43. PubMed ID: 26738780
[TBL] [Abstract][Full Text] [Related]
10. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
11. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
12. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
13. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.
Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Digiovanni J; Sano S
Mol Carcinog; 2013 Oct; 52(10):760-9. PubMed ID: 22431065
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
[TBL] [Abstract][Full Text] [Related]
16. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
17. Cornuside alleviates psoriasis-like skin lesions in mice by relieving inflammatory effects.
Yan F; Wang L; Zhang J; Liu Z; Yu B; Li W; Guo Z; Shi D; Zhang H; Xiong H
Int Immunopharmacol; 2024 Jun; 134():112183. PubMed ID: 38705031
[TBL] [Abstract][Full Text] [Related]
18. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH
Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548
[TBL] [Abstract][Full Text] [Related]
19. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629
[TBL] [Abstract][Full Text] [Related]
20. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression.
Han L; Sun J; Lu CJ; Zhao RZ; Lu Y; Lin HJ; Wei JA
Int Immunopharmacol; 2017 Mar; 44():226-233. PubMed ID: 28129604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
